T-cell engager

Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
PR Newswire
Thu, 11/7/24 - 11:23 am
Aditum Bio
Leads Biolabs
Oblenio Bio
Joe Jimenez
autoimmune disease
T-cell engager
AbbVie taps T-cell engager tech from EvolveImmune to build next-gen cancer biologics
First Word Pharma
Thu, 10/31/24 - 09:39 am
AbbVie
EvolveImmune
T-cell engager
GSK to pay $300M to license drug it sees as potential lupus treatment
BioPharma Dive
Tue, 10/29/24 - 11:38 am
GSK
China
Chimagen
lupus
T-cell engager
Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease
BioPharma Dive
Mon, 09/9/24 - 10:56 am
Candid Therapeutics
T-cell engager
RayzeBio
autoimmune disease
funding
After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab
Fierce Pharma
Mon, 08/26/24 - 11:20 am
Regeneron
Europe
FDA
Ordspono
bispecifics
T-cell engager
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors
BioSpace
Wed, 07/10/24 - 11:11 am
Amgen
T-cell engager
AMG 794
solid tumors
clinical trials
Ipsen gets hot on cold tumors, inking $1.2B biobucks deal for Marengo's T-cell engagers
Fierce Biotech
Fri, 06/7/24 - 11:20 am
Ipsen
Marengo Therapeutics
cold tumors
T-cell engager
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers
BioSpace
Wed, 03/20/24 - 11:28 am
Clasp Therapeutics
funding
T-cell engager
Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus collab
Fierce Biotech
Wed, 03/6/24 - 11:30 am
Gilead Sciences
Merus
T-cell engager
Janux shares triple on early cancer immunotherapy data
BioPharma Dive
Wed, 02/28/24 - 11:08 am
Janux Therapeutics
clinical trials
solid tumors
prostate cancer
T-cell engager
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Fierce Biotech
Mon, 01/8/24 - 11:36 am
Merck
Harpoon Therapeutics
M&A
T-cell engager
JPMHC 2024
Amgen’s T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer
BioSpace
Fri, 10/20/23 - 11:34 am
Amgen
bispecific antibodies
T-cell engager
tarlatamab
clinical trials
FDA to decide on Roche’s lymphoma drug Lunsumio before year-end
Pharmaforum
Wed, 07/6/22 - 10:49 am
Roche
Lunsumio
follicular lymphoma
T-cell engager
FDA
priority review
From partner to part of the family: Takeda pulls the trigger on Maverick buyout
Fierce Biotech
Tue, 03/9/21 - 10:32 am
Takeda
Maverick Therapeutics
M&A
T-cell engager
Janux raises $56M to take safer T-cell engagers into the clinic
Fierce Biotech
Thu, 03/4/21 - 09:54 am
Janux Therapeutics
T-cell engager
Janux pairs up with Merck for $1B-plus T-cell engager deal
Fierce Biotech
Fri, 12/18/20 - 11:04 am
Merck
Janux Therapeutics
R&D
T-cell engager
cancer
Amunix raises $73M to take T-cell engager into humans
Fierce Biotech
Wed, 03/4/20 - 10:27 am
Amunix
T-cell engager
Affimed scraps T-cell engager program, parts company with CSO
Fierce Biotech
Thu, 05/23/19 - 11:06 pm
Affimed
bispecific antibodies
T-cell engager
cancer